- Home
- IMUX vs IH Comparison
IMUX vs IH Comparison
Compare IMUX & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- IH
- Stock Information
- Founded
- IMUX 2016
- IH 1996
- Country
- IMUX United States
- IH China
- Employees
- IMUX N/A
- IH N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- IH Other Consumer Services
- Sector
- IMUX Health Care
- IH Real Estate
- Exchange
- IMUX Nasdaq
- IH Nasdaq
- Market Cap
- IMUX 86.3M
- IH 118.5M
- IPO Year
- IMUX N/A
- IH 2020
- Fundamental
- Price
- IMUX $1.14
- IH $2.51
- Analyst Decision
- IMUX Strong Buy
- IH
- Analyst Count
- IMUX 6
- IH 0
- Target Price
- IMUX $12.67
- IH N/A
- AVG Volume (30 Days)
- IMUX 901.5K
- IH 144.3K
- Earning Date
- IMUX 03-18-2025
- IH 03-25-2025
- Dividend Yield
- IMUX N/A
- IH 3.56%
- EPS Growth
- IMUX N/A
- IH N/A
- EPS
- IMUX N/A
- IH 0.28
- Revenue
- IMUX N/A
- IH $134,002,994.00
- Revenue This Year
- IMUX N/A
- IH $15.90
- Revenue Next Year
- IMUX N/A
- IH $8.64
- P/E Ratio
- IMUX N/A
- IH $8.63
- Revenue Growth
- IMUX N/A
- IH N/A
- 52 Week Low
- IMUX $0.92
- IH $1.47
- 52 Week High
- IMUX $2.11
- IH $2.48
- Technical
- Relative Strength Index (RSI)
- IMUX 54.68
- IH 63.59
- Support Level
- IMUX $1.06
- IH $1.92
- Resistance Level
- IMUX $1.16
- IH $2.40
- Average True Range (ATR)
- IMUX 0.09
- IH 0.14
- MACD
- IMUX -0.00
- IH 0.03
- Stochastic Oscillator
- IMUX 46.87
- IH 66.89
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. The majority of iHuman Inc's revenue comes from mainland China.